超声黏度成像在乳腺病变中的应用:一项多中心前瞻性研究
这项多中心前瞻性研究纳入639例乳腺病变患者,建立开发队列与验证队列,以组织学为参考标准,筛选出鉴别乳腺病变的最优黏度参数A'-S2-Vmax(AUC 0.88),并以>9.97 Pa.s为阈值对BI-RADS进行修订;修订后BI-RADS的AUC在开发队列、验证队列和总队列中均显著提高(P<.05)。
要点
- 超声黏度成像参数A'-S2-Vmax鉴别乳腺病变的AUC为0.88(95%CI: 0.84, 0.91)。
- 以>9.97 Pa.s为阈值修订BI-RADS后,各队列AUC均显著提高(P<.05)。
- 修订后BI-RADS在开发、验证和总队列的AUC分别为0.91、0.90和0.90。
核心结论
- 超声黏度成像评估的定量黏性参数与BI-RADS联合有助于乳腺癌诊断。
研究设计与样本
- 多中心前瞻性研究,2021年6月至2022年11月纳入639例乳腺病变患者(平均年龄46岁±14),建立开发队列(392例)和验证队列(247例),以组织学结果为参考标准。
诊断标准与关键数值
- 在开发队列中,鉴别乳腺病变的最优黏度参数为A'-S2-Vmax,AUC为0.88(95%CI: 0.84, 0.91);以>9.97 Pa.s为截断值修订BI-RADS后,AUC在开发队列从0.85(95%CI: 0.81, 0.88)升至0.91(95%CI: 0.87, 0.93),在验证队列从0.85(95%CI: 0.80, 0.89)升至0.90(95%CI: 0.85, 0.93),在总队列从0.85(95%CI: 0.82, 0.87)升至0.90(95%CI: 0.88, 0.92),所有P<.05。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: To explore and validate the clinical value of ultrasound (US) viscosity imaging in differentiating breast lesions by combining with BI-RADS, and then comparing the diagnostic performances with BI-RADS alone.
MATERIALS AND METHODS: This multicenter, prospective study enrolled participants with breast lesions from June 2021 to November 2022. A development cohort (DC) and validation cohort (VC) were established. Using histological results as reference standard, the viscosity-related parameter with the highest area under the receiver operating curve (AUC) was selected as the optimal one. Then the original BI-RADS would upgrade or not based on the value of this parameter. Finally, the results were validated in the VC and total cohorts. In the DC, VC and total cohorts, all breast lesions were divided into the large lesion, small lesion and overall groups respectively.
RESULTS: A total of 639 participants (mean age, 46 years ± 14) with 639 breast lesions (372 benign and 267 malignant lesions) were finally enrolled in this study including 392 participants in the DC and 247 in the VC. In the DC, the optimal viscosity-related parameter in differentiating breast lesions was calculated to be A'-S2-Vmax, with the AUC of 0.88 (95% CI: 0.84, 0.91). Using > 9.97 Pa.s as the cutoff value, the BI-RADS was then modified. The AUC of modified BI-RADS significantly increased from 0.85 (95% CI: 0.81, 0.88) to 0.91 (95% CI: 0.87, 0.93), 0.85 (95% CI: 0.80, 0.89) to 0.90 (95% CI: 0.85, 0.93) and 0.85 (95% CI: 0.82, 0.87) to 0.90 (95% CI: 0.88, 0.92) in the DC, VC and total cohorts respectively (P < .05 for all).
CONCLUSION: The quantitative viscous parameters evaluated by US viscosity imaging contribute to breast cancer diagnosis when combined with BI-RADS.
引用
- Jia W, Xia S, Jia X, et al. Ultrasound Viscosity Imaging in Breast Lesions: A Multicenter Prospective Study. Acad Radiol. 2024. PMID: 38582684. doi:10.1016/j.acra.2024.03.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。